Characterization of Hepatitis B Virus in Tenofovir-Treated and Untreated Chronically Infected Mothers and Their Immunoprophylaxis Failure Infants
Clinical Infectious Diseases · 2023
DOI: 10.1093/cid/ciac539 ↗Kurz gefasst
Klinische Studie in der Zeitschrift Clinical Infectious Diseases, 2023. Verfasst von Hong-Yuan Hsu und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, National Taiwan University College of Medicine and Hospital, Taipei, Taiwan. Hauptthemen laut MEDLINE: Hepatitis B, Pregnancy Complications, Infectious. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: Ministry of Science and Technology, Taiwan, Liver Disease Prevention and Treatment Research Foundation, Taiwan.
Abstract (Originalsprache)
Background
Maternal tenofovir disoproxil fumarate (TDF) therapy during late pregnancy can reduce mother-to-infant transmission of hepatitis B virus (HBV). We investigated HBV mutations associated with maternal TDF therapy and their role in infant immunonophylaxis failure (IPF).
Methods
Serum samples from untreated (n = 89) and TDF-treated (n = 68), highly viremic, chronically infected mothers and their infants were analyzed for HBV DNA by nested polymerase chain reaction (PCR) and direct sequencing.
Results
At delivery, compared with untreated mothers, TDF-treated mothers had a lower HBV DNA titer and a higher frequency of basal core promoter (BCP) gene mutations, but they had similar frequencies in pre-S/S and pre-core/core mutations. The 14 mothers harboring surface “a” determinant mutants did not transmit the mutants to their immunized infants. Such mutants were found in 3 of 13 IPF infants; the 13 mothers had wild-type hepatitis B surface antigen (HBsAg). In univariable analysis, maternal HBV DNA titer (odds ratio [OR]: 1.54; 95% confidence intervals [CI]: 1.02–2.33; P = .039), genotype C (OR: 4.18; 95% CI: 1.28–13.62; P = .018) and pre-S1 wild-type sequence (OR: 6.33; 95% CI: 1.85–21.68; P = .003) at delivery were associated with infant IPF. Multivariable analyses showed that maternal genotype C (OR: 3.71; 95% CI: 1.11–12.36; P = .033) and pre-S1 wild-type (OR: 6.34; 95% CI: 1.79–22.44; P = .004) were associated with infant IPF independently of maternal viremia.
Conclusions
Along with high maternal HBV DNA titer at delivery, maternal genotype C and pre-S1 wild-type sequence were potential risk factors for infant IPF, although BCP mutations were not. The offspring of pregnant women harboring “a” determinant mutants as major strains seemed to be protected by immunoprophylaxis. Clinical Trials Registration NCT01312012.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, National Taiwan University College of Medicine and Hospital, Taipei, Taiwan.
- Department and Graduate Institute of Medical Education and Bioethics National Taiwan University College of Medicine, Taipei, Taiwan.
- Division of Pediatric Gastroenterology, Department of Pediatrics; Liver Research Center, Chang Gung Memorial Hospital, Linkou Branch, Taiwan.
- Department of Pediatrics, Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan.
- Department of Pediatrics, Cardinal Tien Hospital, and School of Medicine, Fu-Jen Catholic University, New Taipei City, Taiwan.
- Department of Pediatrics, Chang Gung Memorial Hospital, Taipei Branch, Taiwan.
Förderung
- Ministry of Science and Technology, Taiwan
- Liver Disease Prevention and Treatment Research Foundation, Taiwan
Zitieren
APA
Hsu, H. Y., Chen, H. L., Chiang, C. L., Lai, M. W., Mu, S. C., Wen, W. H., Cheng, S. W., Hu, J. J., Chang, K. C., Lee, C. N., Liu, C. J., Wu, J. F., Ni, Y. H., Chang, M. H., & Taiwan Study Group for the Prevention of Mother-to-Infant Transmission of HBV (PreMIT study) (2023). Characterization of Hepatitis B Virus in Tenofovir-Treated and Untreated Chronically Infected Mothers and Their Immunoprophylaxis Failure Infants. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciac539
Vancouver
Hsu HY, Chen HL, Chiang CL, Lai MW, Mu SC, Wen WH, et al. Characterization of Hepatitis B Virus in Tenofovir-Treated and Untreated Chronically Infected Mothers and Their Immunoprophylaxis Failure Infants. Clinical Infectious Diseases. 2023. doi:10.1093/cid/ciac539
BibTeX
@article{Hsu2023,
author = {Hsu, Hong-Yuan and Chen, Huey-Ling and Chiang, Cheng-Lun and Lai, Ming-Wei and Mu, Shu-Chi and Wen, Wan-Hsin and Cheng, Shao-Wen and Hu, Jen-Jan and Chang, Kai-Chi and Lee, Chien-Nan and Liu, Chun-Jen and Wu, Jia-Feng and Ni, Yen-Hsuan and Chang, Mei-Hwei and Taiwan Study Group for the Prevention of Mother-to-Infant Transmission of HBV (PreMIT study), Taiwan Study Group for the Prevention of Mother-to-Infant Transmission of HBV (PreMIT study)},
title = {Characterization of Hepatitis B Virus in Tenofovir-Treated and Untreated Chronically Infected Mothers and Their Immunoprophylaxis Failure Infants},
journal = {Clinical Infectious Diseases},
year = {2023},
doi = {10.1093/cid/ciac539}
}
EUVIMED